GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sonendo Inc (OTCPK:SONX) » Definitions » Debt-to-EBITDA

Sonendo (Sonendo) Debt-to-EBITDA : -1.07 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Sonendo Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sonendo's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $26.32 Mil. Sonendo's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $14.04 Mil. Sonendo's annualized EBITDA for the quarter that ended in Dec. 2023 was $-37.78 Mil. Sonendo's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -1.07.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sonendo's Debt-to-EBITDA or its related term are showing as below:

SONX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.81   Med: -0.74   Max: -0.66
Current: -0.74

During the past 5 years, the highest Debt-to-EBITDA Ratio of Sonendo was -0.66. The lowest was -0.81. And the median was -0.74.

SONX's Debt-to-EBITDA is ranked worse than
100% of 430 companies
in the Medical Devices & Instruments industry
Industry Median: 1.245 vs SONX: -0.74

Sonendo Debt-to-EBITDA Historical Data

The historical data trend for Sonendo's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonendo Debt-to-EBITDA Chart

Sonendo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
-0.66 -0.81 -0.71 -0.77 -0.74

Sonendo Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.02 -0.73 -0.63 -0.66 -1.07

Competitive Comparison of Sonendo's Debt-to-EBITDA

For the Medical Devices subindustry, Sonendo's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonendo's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sonendo's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sonendo's Debt-to-EBITDA falls into.



Sonendo Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sonendo's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(26.316 + 14.035) / -54.768
=-0.74

Sonendo's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(26.316 + 14.035) / -37.784
=-1.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Sonendo  (OTCPK:SONX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sonendo Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sonendo's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonendo (Sonendo) Business Description

Traded in Other Exchanges
N/A
Address
26061 Merit Circle, Suite 102, Laguna Hills, CA, USA, 92653
Sonendo Inc is a commercial-stage medical technology company focused on saving teeth from tooth decay, the prevalent chronic disease globally. It has developed the GentleWave System, a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The Company operates in two business segments, Product and Software. Product segment includes sales of the Company's GentleWave System console and related accessories and instruments. Software segment includes sales of the Company's traditional software licenses for practice management software to enable an integrated digital office for endodontists.
Executives
Bjarne Bergheim director, officer: President and CEO C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Roy T Chen officer: Chief Talent Officer C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Michael Patrick Watts officer: Chief Financial Officer C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Olav Bergheim director, 10 percent owner ONE PALMER SQUARE, PRINCETON NJ 08542
Pudipeddi Vamsi Mohan Raj director 2820 ORCHARD PARKWAY, SAN JOSE CA 95134
Michael John Smith officer: Chief Commercial Officer C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Andrew J Kirkpatrick officer: Chief Operating Officer 1310 CHESAPEAKE TERRACE, SUNNYVALE CA 94089
General Atlantic, L.p. director, 10 percent owner 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
Bihl Anthony P Iii director 807 SMITH RIDGE ROAD, NEW CANAAN CT 06840
Mehrezad Khakpour officer: Chief Technology Officer C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Jacqueline Arnold Collins officer: VP, General Counsel C/O SONENDO, INC., 2601 MERIT CIRCLE, SUITE 102, LAGUNA HILLS CA 92653
Carolyn Beaver director 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121
General Atlantic (soi), L.p. 10 percent owner C/O GENERAL ATLANTIC SERVICE COMPANY, LP, 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
General Atlantic Partners (bermuda) Eu, L.p. 10 percent owner C/O GENERAL ATLANTIC SERVICE COMPANY LP, 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055
Gap Coinvestments V, Llc 10 percent owner 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055